- News and Insights
- About Us
BioBasics 101: The Biology of Biotech for the Non-Scientist is an intensive course that explains the foundational science upon which all biopharma therapies are based. Day one focuses on the function of DNA, RNA, proteins, and cell signaling and how each interacts in both healthy and diseased tissue. Day two builds on your newfound molecular biology knowledge. This includes a more in-depth look at genetic disease and how genetic engineering is used to create personalized medicine options for patients. The course ends with a survey of small molecule drugs, biologics, and vaccines and explains how each mitigates disease at the molecular level. BioBasics 101 will increase your scientific knowledge so that you can converse more effectively with colleagues, clients, regulators, and scientists.
BioBasics 101 was developed for the non-science professional who works within or services the biopharma industry. Click here to view the program agenda.
Who should attend
Non-science professionals from all sectors, including finance, legal, sales, marketing, HR, manufacturing, management, government relations, IT, project management, regulatory affairs, supply chain, safety, and tech transfer. For anyone working on the “business side” needs to better understand and communicate with the “science side.” Past participants include:
– Venture capitalists, angel investors, bankers, analysts, financial managers
– Insurance brokers, real estate professionals
– Patient advocacy group staff, disease foundation members
– Policymakers, lobbyists, attorneys
– Consultants, public relations specialists, journalists
– University administrators, research institute support staff
– Environmental, health, and safety engineers
CLS Members save even more with early bird registration – register before March 15 to secure these savings!
CLS members | Early bird: $1295; Regular: $1495
Non-member | Early bird: $1395; Regular: $1595